Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

A recent study reveals that resveratrol, a compound present in red wine, may hold the key to effectively treating depression and anxiety without the need for drugs.

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

Scientists uncover rapid-acting, low-side-effect antidepressant target New study highlights the molecular and cellular mechanisms underlying the antidepressant effect of delta opioid receptor agonists ...

This paper reviews recent findings on the pharmacogenetics of antidepressant drugs and future clinical applications. Ultimately, these studies should lead to the use of genetic testing to guide ...

They are now the most commonly prescribed antidepressant medications. They are prescribed to treat depression but are also used to treat a broader range of depressive disorders, anxiety disorders, and ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...